Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) GlobeNewswire August 01, 2025 CAMBRIDGE, Mass., Aug. 01, 2025 (GLOBE NEWSWIRE) — Akebia Therapeutics(R), Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease, granted four newly-hired employees options to purchase an aggregate of 238,500 shares

Lakeland Fire + Safety Declares Cash Dividend for Third Quarter 2026

Lakeland Fire + Safety Declares Cash Dividend for Third Quarter 2026 GlobeNewswire August 01, 2025 HUNTSVILLE, Ala., Aug. 01, 2025 (GLOBE NEWSWIRE) — Lakeland Industries, Inc. (“Lakeland Fire + Safety” or “Lakeland”) (NASDAQ: LAKE), a leading global manufacturer of protective clothing and apparel for industry, healthcare and first responders, today announced that its Board of

New Richmond American Community Now Selling in Rancho Cordova

Highly anticipated Seasons at Cypress is currently open for sales by appointment only Richmond American Homes of Maryland, Inc., California Department of Real Estate – Real Estate Broker, Corporation License Number 01842595, is pleased to announce that Seasons at Cypress (RichmondAmerican.com/SeasonsAtCypress) is now open for sales by appointment in Rancho Cordova. This exciting new community

TEXAS COMMUNITY BANCSHARES, INC. REPORTS UNAUDITED FINANCIAL RESULTS FOR THE SECOND QUARTER ENDED JUNE 30, 2025

Texas Community Bancshares, Inc. (“Texas Community Bancshares” or the “Company”) (NASDAQ: TCBS), the holding company for Broadstreet Bank, SSB, today reported net income of $678,000 for the three months ended June 30, 2025 and $1.3 million for the six months ended June 30, 2025 compared to net income of $348,000 for the three months ended

Thornburg Income Builder Opportunities Trust Announces Distribution

Thornburg Income Builder Opportunities Trust (the “Trust”) (NASDAQ: TBLD) today announced a monthly distribution of $0.10417 per share on the Trust's common shares, payable on August 20, 2025, to common shareholders of record as of August 11, 2025. https://mma.prnewswire.com/media/1716788/Thornburg_Logo.jpg The Trust's monthly distribution is shown below: Amount Payable Date Ex-Dividend/Record Date Change from Previous Declaration$0.10417

AMGEN ANNOUNCES 2025 THIRD QUARTER DIVIDEND

Amgen (NASDAQ:AMGN) today announced that its Board of Directors declared a $2.38 per share dividend for the third quarter of 2025. The dividend will be paid on September 12, 2025, to all stockholders of record as of the close of business on August 22, 2025. About Amgen Amgen discovers, develops, manufactures and delivers innovative medicines

Prime Medicine Announces Closing of Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares

(NasdaqGM:PRME), CAMBRIDGE, Mass., Aug. 01, 2025 (GLOBE NEWSWIRE) — Prime Medicine, Inc. (Nasdaq: PRME), a biotechnology company committed to delivering a new class of differentiated one-time curative genetic therapies, today announced the closing of its underwritten public offering of 43,700,000 shares of its common stock, which includes the full exercise of the underwriters' option to

Taitron Announces Quarterly Cash Dividend

(NASDAQ:TAIT), LOS ANGELES, Aug. 01, 2025 (GLOBE NEWSWIRE) — Taitron Components Incorporated (NASDAQ:TAIT) today announced that its Board of Directors has declared a quarterly cash dividend of $0.035 per share of common stock, payable on August 29, 2025 to stockholders of record as of the close of business on August 15, 2025. Under our current

Prime Medicine Announces Closing of Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares

Prime Medicine Announces Closing of Public Offering and Full Exercise of the Underwriters' Option to Purchase Additional Shares GlobeNewswire August 01, 2025 CAMBRIDGE, Mass., Aug. 01, 2025 (GLOBE NEWSWIRE) — Prime Medicine, Inc. (Nasdaq: PRME), a biotechnology company committed to delivering a new class of differentiated one-time curative genetic therapies, today announced the closing of

Scroll to Top